These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 6540087
1. Physico-chemical properties and stabilities of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212). Shimizu T, Osumi T, Niimi K, Nakagawa K. Arzneimittelforschung; 1984; 34(3A):334-41. PubMed ID: 6540087 [Abstract] [Full Text] [Related]
2. Physico-chemical properties and stabilities of the highly potent calcium antagonist benidipine hydrochloride. Suzuki H, Ono E, Ueno H, Takemoto Y, Nakamizo N. Arzneimittelforschung; 1988 Nov; 38(11A):1671-6. PubMed ID: 3219139 [Abstract] [Full Text] [Related]
3. Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog. Grupp G, Grupp IL, Newman G, Schwartz A. Arzneimittelforschung; 1984 Nov; 34(3A):359-63. PubMed ID: 6540089 [Abstract] [Full Text] [Related]
4. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics. Inoue M, Hori M, Nakajima S, Kitakaze M, Fukunami M, Ishida Y, Abe H. Arzneimittelforschung; 1984 Nov; 34(3A):355-9. PubMed ID: 6540088 [Abstract] [Full Text] [Related]
5. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals. Yamashita S, Hosokawa T, Kojima M, Mori T, Yabuuchi Y. Arzneimittelforschung; 1984 Nov; 34(3A):342-6. PubMed ID: 6331464 [Abstract] [Full Text] [Related]
8. Studies on the mechanism of action of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic drug. Enzyme activities and Ca2+ transport processes of sarcolemma and intracellular organelles. Schwartz A, Wallick ET, Lee SW, Wang T, Hosakawa T, Whitmer KR, Matlib MA. Arzneimittelforschung; 1984 Nov; 34(3A):384-9. PubMed ID: 6540093 [Abstract] [Full Text] [Related]
11. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure. Hashimoto K, Yabuuchi Y, Yamashita S, Mori T. Arzneimittelforschung; 1984 Nov; 34(3A):390-3. PubMed ID: 6540094 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey. Miyamoto G, Sasabe H. Arzneimittelforschung; 1984 Nov; 34(3A):394-402. PubMed ID: 6540095 [Abstract] [Full Text] [Related]
15. High-performance liquid chromatographic procedure for the determination of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-(dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone, in human plasma and urine. Miyamoto G, Sasabe H, Odomi M, Shimizu T. J Chromatogr; 1985 Mar 22; 338(2):450-5. PubMed ID: 3998030 [No Abstract] [Full Text] [Related]